SG10201602076QA - Glycosylated polypeptide and pharmaceutical composition containing same - Google Patents
Glycosylated polypeptide and pharmaceutical composition containing sameInfo
- Publication number
- SG10201602076QA SG10201602076QA SG10201602076QA SG10201602076QA SG10201602076QA SG 10201602076Q A SG10201602076Q A SG 10201602076QA SG 10201602076Q A SG10201602076Q A SG 10201602076QA SG 10201602076Q A SG10201602076Q A SG 10201602076QA SG 10201602076Q A SG10201602076Q A SG 10201602076QA
- Authority
- SG
- Singapore
- Prior art keywords
- pharmaceutical composition
- composition containing
- containing same
- glycosylated polypeptide
- glycosylated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
- C07K1/026—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution by fragment condensation in solution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011218793 | 2011-10-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201602076QA true SG10201602076QA (en) | 2016-04-28 |
Family
ID=47995870
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201602076QA SG10201602076QA (en) | 2011-10-01 | 2012-09-28 | Glycosylated polypeptide and pharmaceutical composition containing same |
| SG11201401071YA SG11201401071YA (en) | 2011-10-01 | 2012-09-28 | Glycosylated polypeptide and pharmaceutical composition containing same |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201401071YA SG11201401071YA (en) | 2011-10-01 | 2012-09-28 | Glycosylated polypeptide and pharmaceutical composition containing same |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10358470B2 (en) |
| EP (1) | EP2762489B1 (en) |
| JP (1) | JP6153470B2 (en) |
| KR (1) | KR101979045B1 (en) |
| CN (2) | CN104080803B (en) |
| AU (1) | AU2012317325B2 (en) |
| BR (1) | BR112014007766B1 (en) |
| CA (1) | CA2850469C (en) |
| DK (1) | DK2762489T3 (en) |
| IN (1) | IN2014CN02982A (en) |
| MY (1) | MY168902A (en) |
| RU (1) | RU2636456C2 (en) |
| SG (2) | SG10201602076QA (en) |
| TW (1) | TWI633115B (en) |
| WO (1) | WO2013047846A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10358470B2 (en) | 2011-10-01 | 2019-07-23 | Glytech, Inc. | Glycosylated polypeptide and pharmaceutical composition containing same |
| MY171183A (en) | 2013-03-29 | 2019-09-30 | Glytech Inc | Polypeptide glycosylated with sialylated sugar chain |
| CN114685645A (en) * | 2020-12-30 | 2022-07-01 | 深圳翰宇药业股份有限公司 | Synthetic method of somaglutide |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0237019A3 (en) * | 1986-03-14 | 1988-03-09 | Toray Industries, Inc. | Interferon conjugate and production thereof using recombinant gene |
| IL130964A0 (en) | 1997-01-16 | 2001-01-28 | Cytel Corp | Practical in vitro sialylation of recombinant glycoproteins |
| DE19717864C2 (en) | 1997-04-23 | 2001-05-17 | Fraunhofer Ges Forschung | Human recombinant interferon beta, process for its preparation and its use |
| CN1187094C (en) * | 1998-04-28 | 2005-02-02 | 应用研究系统Ars股份公司 | Polyol-IFN-beta conjugates |
| AU762616B2 (en) | 1998-10-16 | 2003-07-03 | Biogen Ma Inc. | Polymer conjugates of interferon beta-1a and uses |
| PL200586B1 (en) * | 1998-10-16 | 2009-01-30 | Biogen Idec Inc | Polypeptides containing interferon-beta-1a mutants, their encoding nucleic acid molecules, host cells transformed by these molecules, method for the manufacture of polypeptides, polypeptides containing pharmaceutical compounds and polypeptide applications |
| US6514729B1 (en) | 1999-05-12 | 2003-02-04 | Xencor, Inc. | Recombinant interferon-beta muteins |
| ATE385517T1 (en) * | 1999-12-08 | 2008-02-15 | Amgen Inc | INTERFERON-LIKE MOLECULES AND USES THEREOF |
| US7795002B2 (en) * | 2000-06-28 | 2010-09-14 | Glycofi, Inc. | Production of galactosylated glycoproteins in lower eukaryotes |
| AU2001273385B2 (en) | 2000-09-08 | 2005-04-07 | Gryphon Therapeutics, Inc. | Polymer-modified synthetic proteins |
| MXPA03007619A (en) | 2001-02-27 | 2003-12-04 | Maxygen Aps | New interferon beta-like molecules. |
| MXPA03008310A (en) | 2001-03-15 | 2003-12-11 | Merck Patent Gmbh | Modified interferon beta with reduced immunogenicity. |
| EP2292271A3 (en) * | 2001-10-10 | 2011-09-14 | BioGeneriX AG | Remodelling and glycoconjugation of an antibody |
| US7226903B2 (en) | 2001-10-10 | 2007-06-05 | Neose Technologies, Inc. | Interferon beta: remodeling and glycoconjugation of interferon beta |
| WO2003054006A2 (en) | 2001-12-11 | 2003-07-03 | Aventis Pasteur | Mutated hiv tat |
| CA2477577A1 (en) | 2002-03-12 | 2003-09-18 | Maxygen Aps | Interferon beta-like molecules for treatment of stroke |
| US7943763B2 (en) | 2002-07-05 | 2011-05-17 | Otsuka Chemical Holdings Co., Ltd. | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides |
| WO2004020468A2 (en) | 2002-08-28 | 2004-03-11 | Maxygen Aps | Interferon beta-like molecules for treatment of cancer |
| RS20050255A (en) * | 2002-09-27 | 2007-08-03 | Biogen Idec Ma Inc., | Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-betha |
| CA2500626A1 (en) | 2002-10-01 | 2004-04-15 | Xencor, Inc. | Interferon variants with improved properties |
| JP4495598B2 (en) | 2002-12-26 | 2010-07-07 | 康宏 梶原 | Sugar chain asparagine derivative and method for producing the same |
| JP4850514B2 (en) | 2003-08-25 | 2012-01-11 | 東レ株式会社 | Interferon β complex |
| WO2005084303A2 (en) | 2004-03-01 | 2005-09-15 | Enzon Pharmaceuticals, Inc. | Interferon-beta polymer conjugates |
| RU2392963C2 (en) * | 2004-08-09 | 2010-06-27 | Элиоз Байофарма, Инк. | Synthetic versions of hyperglycolised protease-resistive polypeptide, oral compositions and methods of using such versions |
| EP1789074A4 (en) | 2004-08-09 | 2009-08-12 | Alios Biopharma Inc | Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same |
| KR100781666B1 (en) | 2004-11-02 | 2007-12-03 | 신영기 | Human Interferon-beta Mutein |
| EP1917276B1 (en) * | 2005-08-26 | 2018-03-21 | Ares Trading S.A. | Process for the preparation of glycosylated interferon beta |
| US20080003202A1 (en) * | 2006-03-28 | 2008-01-03 | Thierry Guyon | Modified interferon-beta (IFN-beta) polypeptides |
| US20080096819A1 (en) | 2006-05-02 | 2008-04-24 | Allozyne, Inc. | Amino acid substituted molecules |
| RU2539829C2 (en) * | 2007-06-19 | 2015-01-27 | ГЛИТЕК,ИНК.,Япония | Glp-1 peptide having attached oligosaccharide chain |
| DK2184290T3 (en) * | 2007-07-31 | 2015-05-26 | Glytech Inc | PROCEDURE FOR PEPTID PREPARATION |
| JP2009242372A (en) | 2008-03-11 | 2009-10-22 | Yokohama City Univ | Erythropoietin derivative having uniform sugar chain structure |
| RU2543157C2 (en) | 2008-06-17 | 2015-02-27 | Глитек,Инк. | Glycated peptide glp-1 |
| US8815580B2 (en) * | 2008-08-08 | 2014-08-26 | Vib Vzw | Cells producing glycoproteins having altered glycosylation patterns and method and use thereof |
| US20110262945A1 (en) * | 2008-08-19 | 2011-10-27 | Otsuka Chemical Co., Ltd. | Glycoprotein production method and screening method |
| WO2012051615A1 (en) | 2010-10-15 | 2012-04-19 | Transgenrx, Inc. | Novel vectors for production of glycosylated interferon |
| EP2684899B1 (en) | 2011-03-10 | 2018-04-25 | Glytech, Inc. | Method for producing glycopeptide having sialyl sugar chain, sialyl sugar chain-added amino acid derivative to be used in same, and glycopeptide |
| JP6151640B2 (en) | 2011-06-29 | 2017-06-21 | 協和発酵キリン株式会社 | Protein purification method |
| US10358470B2 (en) | 2011-10-01 | 2019-07-23 | Glytech, Inc. | Glycosylated polypeptide and pharmaceutical composition containing same |
-
2012
- 2012-09-28 US US14/347,222 patent/US10358470B2/en active Active
- 2012-09-28 MY MYPI2014000925A patent/MY168902A/en unknown
- 2012-09-28 SG SG10201602076QA patent/SG10201602076QA/en unknown
- 2012-09-28 EP EP12836998.0A patent/EP2762489B1/en active Active
- 2012-09-28 WO PCT/JP2012/075262 patent/WO2013047846A1/en active Application Filing
- 2012-09-28 RU RU2014116550A patent/RU2636456C2/en active
- 2012-09-28 CN CN201280058952.8A patent/CN104080803B/en active Active
- 2012-09-28 BR BR112014007766-5A patent/BR112014007766B1/en active IP Right Grant
- 2012-09-28 DK DK12836998.0T patent/DK2762489T3/en active
- 2012-09-28 CA CA2850469A patent/CA2850469C/en active Active
- 2012-09-28 AU AU2012317325A patent/AU2012317325B2/en active Active
- 2012-09-28 IN IN2982CHN2014 patent/IN2014CN02982A/en unknown
- 2012-09-28 KR KR1020147010631A patent/KR101979045B1/en active IP Right Grant
- 2012-09-28 SG SG11201401071YA patent/SG11201401071YA/en unknown
- 2012-09-28 JP JP2013536471A patent/JP6153470B2/en active Active
- 2012-09-28 CN CN201811042210.1A patent/CN109134642A/en active Pending
- 2012-10-01 TW TW101136177A patent/TWI633115B/en active
Also Published As
| Publication number | Publication date |
|---|---|
| JP6153470B2 (en) | 2017-06-28 |
| EP2762489A1 (en) | 2014-08-06 |
| AU2012317325B2 (en) | 2016-10-06 |
| CN109134642A (en) | 2019-01-04 |
| TW201321404A (en) | 2013-06-01 |
| EP2762489A9 (en) | 2015-02-11 |
| KR101979045B1 (en) | 2019-05-15 |
| EP2762489A4 (en) | 2015-05-06 |
| BR112014007766A2 (en) | 2017-04-04 |
| CN104080803B (en) | 2020-08-04 |
| CA2850469A1 (en) | 2013-04-04 |
| IN2014CN02982A (en) | 2015-07-03 |
| CA2850469C (en) | 2020-07-07 |
| EP2762489B1 (en) | 2018-03-28 |
| KR20140095051A (en) | 2014-07-31 |
| US20140369964A1 (en) | 2014-12-18 |
| WO2013047846A1 (en) | 2013-04-04 |
| RU2014116550A (en) | 2015-10-27 |
| RU2636456C2 (en) | 2017-11-23 |
| MY168902A (en) | 2018-12-04 |
| AU2012317325A1 (en) | 2014-04-17 |
| JPWO2013047846A1 (en) | 2015-03-30 |
| TWI633115B (en) | 2018-08-21 |
| US10358470B2 (en) | 2019-07-23 |
| DK2762489T3 (en) | 2018-07-02 |
| BR112014007766B1 (en) | 2022-05-10 |
| CN104080803A (en) | 2014-10-01 |
| SG11201401071YA (en) | 2014-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL262667B (en) | An isolated polynucleotide encoding a polypeptide and a pharmaceutical composition comprising the isolated polynucleotide | |
| SG10201601327RA (en) | Glycosylated polypeptide and drug composition containing said polypeptide | |
| IL253870B (en) | Certain amino-pyrimidines and pharmaceutical compositions comprising them | |
| IL245328B (en) | Pharmaceutical composition comprising carbetocin | |
| ZA201305504B (en) | Compositions containing glycosylated antibodies and uses thereof | |
| HK1199889A1 (en) | Relaxin fusion polypeptides and uses thereof | |
| EP2699590B8 (en) | Endoglin polypeptides and uses thereof | |
| IL230918A0 (en) | Modified proteins and peptides | |
| HK1195793A1 (en) | Combination pharmaceutical compositions and uses thereof | |
| IL230463A0 (en) | Benzamides their preparation and pharmaceutical compositions containing them | |
| SG11201405578TA (en) | Pharmaceutical composition containing peptide | |
| EP2738255A4 (en) | Erap1-derived peptide and use thereof | |
| IL225339A0 (en) | Caspofungin composition | |
| EP2775831A4 (en) | Pharmaceutical compositions and uses thereof | |
| ZA201207375B (en) | Stabilized pharmaceutical composition | |
| SG11201402139UA (en) | High mast2-affinity polypeptides and uses thereof | |
| EP2666482A4 (en) | Particle composition and pharmaceutical composition using particle composition | |
| HK1198910A1 (en) | Pharmaceutical composition comprising ebastine and fluticasone | |
| SG10201602076QA (en) | Glycosylated polypeptide and pharmaceutical composition containing same | |
| SG11201400289SA (en) | Glycosylated polypeptide and drug composition containing said polypeptide | |
| EP2743252A4 (en) | Tetravalent platinum complex and pharmaceutical composition containing same | |
| IL221501A (en) | Pharmaceutical composition comprising myramistin | |
| PT2918267T (en) | Particulate pharmaceutical composition | |
| EP2751129A4 (en) | Protein p14 with anti-cancer and anti-allergy activity and pharmaceutical composition comprising the same | |
| ZA201309537B (en) | Pharmaceutical composition comprising fexofedine |